European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-24

Generation and functional characterization of neuroendocrine cells for cellular replacement therapy (GROWBETA)

Cel

New insights into the molecular biology of signals, which control cellular function and differentiation, open novel approaches towards treatment of degenerative diseases. Diabetes mellitus is a prototype of such a disease, characterized either by a complete loss of the insulin producing B-cells or by impaired regulation of secretion. We want to combine the expertise of developmental biologists, neuroscientists, and cell biologists, to provide basic knowledge on how precursor cells can be induced to develop a secretory phenotype. Next, we want to study, how such cells are influenced in their function by a set of signals, which is shared by neurons and endocrine cells. Regarding diabetes, the challenge for cellular replacement therapy is not only to grow islet-like tissue, but also to achieve the uninterrupted control of blood glucose levels. The simplicity of islets should provide a testing ground for general strategies

Zaproszenie do składania wniosków

Data not available

System finansowania

CSC - Cost-sharing contracts

Koordynator

MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Wkład UE
Brak danych
Adres
Waldweg 33
37073 GOETTINGEN
Niemcy

Zobacz na mapie

Koszt całkowity
Brak danych

Uczestnicy (5)